UNSPSC 51433900: Antihypertensive pyridines

Antihypertensive drugs made from compounds with a six membered aromatic ring containing nitrogen.

UNSPSC 51433900 Antihypertensive pyridines (Class) encompasses cardiovascular medications—specifically antihypertensive agents in the pyridine chemical family—that state and local governments procure for emergency medical services, pharmacy benefit programs, and public health agencies. State and local buyers under this code include city fire and rescue departments, state health and human services commissions, and multistate cooperative purchasing alliances serving state agencies and local government facilities. The scope of work ranges from direct supply of finished pharmaceutical products to emergency responders to participation in statewide and multi-jurisdictional pharmacy benefit contracts that require manufacturers to meet FDA compliance, Good Manufacturing Practices certification, Drug Supply Chain Security Act compliance, and detailed NDC and pricing documentation.

Recent activity spans Florida, Texas, and Minnesota through a geographic mix of municipal, state, and regional cooperative procurement bodies. The City of Tampa Fire Rescue solicited Advanced Life Support Medications (IFB 26P00188, due April 8, 2026) requesting 1,020 units of Diltiazem 25mg vials and other cardiac drugs for emergency response, with a one-year contract term and a $40,000 estimated value featuring a 5 percent SLBE bid discount. The Texas Health and Human Services Commission issued an RFI (HHS0017013, due April 3, 2026) exploring direct-to-manufacturer prescription programs outside traditional PBM and GPO channels, signaling the state's intent to reshape pharmacy benefit procurement strategy. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, posted an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, requiring manufacturers to meet cGMP and DSCSA standards and accept a 3 percent administrative fee, with contract effectiveness July 1, 2026 across participating states including Oregon.